Informativeness of the thrombodynamic method in assessing the state of hemostasis in patients with coronary heart disease
https://doi.org/10.21886/2219-8075-2019-10-2-48-54
Abstract
Objective: to evaluate the information content of the method of thrombodynamics and local indicators of hemostasis system diagnostics in patients with ischemic heart disease.
Matherials and methods: 59 people took part in the study, 34 of them made up the main group of patients with coronary artery disease and 25 control group with no coronary artery disease in history. The study participants were once assessed the state of hemostasis using “local” methods and global - Thrombodynamics, according to manufacturers instructions. After evaluating the indicators, the main group of patients was ranked according to the presence of comorbidities.
Results: when comparing the hemostasiogram indicators between the main group and the control group, no significant differences were found. Evaluating the indicators of thrombodynamics - there is a statistically significant increase in the blood thrombogenic potential in the main group.
Conclusions: in patients with coronary artery disease, in order to timely detect hemostasis disorders, an integrated approach is needed, consisting not only in conducting local tests of the study, but also global ones.
About the Author
I. F. Shlyk
Rostov Regional Clinical Hospital
Russian Federation
Competing Interests: not
Russian Federation
Irina F. Shlyk - PhD in Medical sciences, cardiologist.
Rostov-on-Don
Competing Interests: not
References
1. Fedotova LA, Zorin VN, Plastun MJu. Hemostasis, fibrinolysis in ischemic heart disease and arterial hypertension. Tavricheskij mediko-biologicheskij vestnik. 2013;16(4):183-186. (In Russ).
2. Stuklov NI. Physiology and pathology of hemostasis. Moscow: GJeOTAR - Media; 2016. (In Russ).
3. Nikiforov JuV, Chernysheva GG, Molchanova LV. Physiology and pathology of hemostasis. Obshhaja reanimatologija. 2009;5:5-8. (In Russ).
4. Wajima T, Isbister GK, Duffull SB. A comprehensive model for the humoral coagulation network in humans. Clin. Pharmacol. Ther. 2009;86(3):290-298. doi: 10.1038/clpt.2009.87.
5. Sin’kov SV, Zabolotskih IB. Diagnosis and correction of the hemostatic system. Moscow: Prakticheskaja medicina; 2017. (In Russ.)
6. Parolari А, Cavallotti L, Andreini D, Myasoedova V, Banfi C, Camera M, et al. D-dimer is associated with arterial and venous coronary artery bypass graft occlusion. The Journal of Thoracic and Cardiovascular Surgery. 2018;155(1):200-207. DOI: 10.1016/j.jtcvs.2017.04.043
7. Koksheneva IV, Klimovich LG, Arutjunova JaJe, Mackeplish-vili ST, Samsonova NN, Buziashvili JuI, et al. The prognostic significance of coagulation hemostasis factors and gene polymorphism in the development of subacute thrombosis in patients with ischemic heart disease after coronary stenting. Tromboz, gemostaz, reologija. 2014;2(58):27-32. (In Russ).
8. Balandina AN, Kolcova EM, Shibeko AM, Kuprash AD, Ataullahanov FI. Thrombodynamics: a new approach to the diagnosis of disorders of the hemostatic system. Voprosy gematologii/onkologii i immunopatologii v pediatrii. 2018;17(4): 114-126. (In Russ). DOI: 10.24287/1726-1708-2018-17-4-114-126
9. Ataullahanov FI, Balandina AN, Vardanjan NM, Verholomo-va FJu, Vujmo TA, Karamzin SS, et al. The use of thrombody-namic test to assess the state of the hemostatic system. Moskva; 2015. (in Russ.)
10. Nomokonova EA, Elykomov VA, Efremushkina AA, Anan’ev DA. Hemostatic system parameters in patients with chronic coronary artery disease before and after coronary artery bypass surgery. Medicinskij almanah. 2016;42(2):31-34. (In Russ.)
11. Porushnichak EB, Kuznik BI. Coagulability and fibrinolytic activity of blood taken from various basins of the vascular bed in patients with IHD. Kubanskij nauchnyj medicinskij vestnik. 2009;1:101-104. (In Russ).
12. Peshkova AD, Lozhkin AP, Fathullina LS, Maljasjov DV, Bre-dihin RA, Litvinov RI. Dependence of the contraction (retraction) of the clot on the molecular and cellular composition of the blood. Kazanskij medicinskij zhurnal. 2016;97(1):70-77. (In Russ). DOI: 10.17750/KMJ2016-70
13. Hugo C. Tissue factor-driven thrombin generation and inflammation in atherosclerosis. Thrombosis Research. 2012;129(2):38-40. Doi: 10.1016/j.thromres.2012.02.028.
14. Borissoff JI, Heeneman S, Kilinc E, Kassak P, Oerle RV, Winckers K. et al. Early atherosclerosis exhibits an enhanced procoagulant state. Circulation. 2010;122:821-830. DOI: 10.1161/CIRCULATIONAHA.109.907121
Review
For citations:
Shlyk I.F. Informativeness of the thrombodynamic method in assessing the state of hemostasis in patients with coronary heart disease. Medical Herald of the South of Russia. 2019;10(2):48-54. (In Russ.) https://doi.org/10.21886/2219-8075-2019-10-2-48-54
Views:
1549
Email this article 